T2D: Real Benefits of New Oral Antidiabetic Drugs T2D: Real Benefits of New Oral Antidiabetic Drugs
Could combining SGLT2 inhibitors with GLP-1R agonists have a cardioprotective and nephroprotective effect for patients with type 2 diabetes?Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
More News: Cardiology | Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Heart | SGLT2 Inhibitors